Two stem cell companies derived from UW-Madison research are coming out of the woodwork.

JangoBio says it is developing ways to reverse hormone imbalances tied to aging without the use of traditional hormone replacement therapy.

Using stem cell technology, JangoBio hopes to restore an individual’s regular hormone levels and, in doing so, delay the onset of diseases associated with aging, such as heart disease and dementia.

“It may be possible, using certain stem cell types that are present in our body and changing them up so they would integrate in the ovary, for example … and generate the hormones that you want to produce,” said Craig Atwood, JangoBio CEO. Read the full story here.